Index Performance
Overview
Description
The healthcare services industry in the U.S. is a robust and dynamic sector, underpinned by the increasing demand for medical services due to demographic shifts such as an aging population, advancements in medical treatments, and a heightened focus on health and wellness precipitated by public health challenges like the COVID-19 pandemic. The growth is also driven by innovation in healthcare technologies and services, such as telemedicine, as well as regulatory changes and governmental policies which influence reimbursement rates and coverage. With the integration of IT in healthcare, the emphasis on cost reduction and outcome improvement, alongside rising insurance coverage, the sector is poised for upward growth. However, it is also susceptible to policy changes, which adds a level of uncertainty to its long-term prospects. Investing within the healthcare services industry can be varied with several subcategories of interest under the given criteria. [[Integrated Healthcare Services]] are businesses that offer a spectrum of services from primary care to specialized surgeries, optimizing coordinated care and potentially offering significant efficiency. [[Healthcare Technology and Data Analytics]] signifies companies that focus on the integration of IT to improve patient care, enhance data management, and support remote healthcare services, which is particularly relevant in an era of increased telemedicine utilization. [[Managed Healthcare Providers]] describes organizations that arrange for the delivery of healthcare services to patients, attempting to reduce healthcare costs while improving quality of care. [[Pharmaceutical Services and Distribution]] encompasses companies involved in the wholesale distribution of pharmaceuticals and health products as well as the provision of value-added services to the healthcare sector. [[Medical Supplies and Devices]] covers firms specializing in the manufacture and supply of medical equipment, which have found increasing demands following global health crises, technological improvements, and the trend of surgeries moving towards outpatient settings. Each of these subcategories have distinct growth drivers and risks, and demand a thorough analysis of financial health, market position, regulatory pressures, and technological adaptability to determine the strongest investment candidates. This index was generated with help from Thematic Assist.
- TickerHCAP
- Inception Date12/03/2023
- WeightingEqual
- # of holdings67
What's inside?
Holdings
All holdings as of July 26, 2024
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2.07% | $30.09B | 54.82% | 86.65% | 9.57 |
| Bristol Myers Squibb Co. (BMY) | 1.76% | $91.77B | 4.66% | 55.54% | 3.46 |
| SS&C Technologies Holdings, Inc. (SSNC) | 1.70% | $16.82B | 6.52% | 48.11% | N/A |
| Avantor, Inc. (AVTR) | 1.69% | $15.50B | -5.65% | 33.96% | 3.28 |
| Viatris, Inc. (VTRS) | 1.69% | $14.00B | -1.70% | 41.57% | 2.06 |
| Paycom Software, Inc. (PAYC) | 1.63% | $9.47B | 10.68% | 77.69% | 6.25 |
| Pfizer Inc. (PFE) | 1.62% | $171.02B | -18.61% | 70.56% | 3.92 |
| IQVIA Holdings, Inc. (IQV) | 1.62% | $42.35B | 2.53% | 27.71% | 3.35 |
| Charles River Laboratories International, Inc. (CRL) | 1.61% | $11.43B | -1.73% | 31.65% | 4.10 |
| Gilead Sciences, Inc. (GILD) | 1.61% | $95.32B | 5.66% | 76.79% | 4.03 |
| Cognizant Technology Solutions Corp. (CTSH) | 1.60% | $36.40B | -1.08% | 31.16% | 1.84 |
| Neurocrine Biosciences, Inc. (NBIX) | 1.60% | $14.70B | 22.57% | 97.52% | 6.87 |
| AbbVie, Inc. (ABBV) | 1.59% | $321.69B | 4.31% | 84.95% | N/A |
| Amgen, Inc. (AMGN) | 1.59% | $179.33B | 22.19% | 56.73% | 7.04 |
| Incyte Corp. (INCY) | 1.59% | $15.42B | 8.93% | 91.24% | 2.42 |
| Sony Group Corp. (SONY) | 1.59% | $106.71B | 5.74% | 31.24% | 1.32 |
| Teleflex, Inc. (TFX) | 1.58% | $10.48B | 3.79% | 56.40% | 4.11 |
| Johnson & Johnson (JNJ) | 1.58% | $384.20B | -12.12% | 68.99% | 4.27 |
| Thermo Fisher Scientific, Inc. (TMO) | 1.57% | $226.93B | -1.37% | 37.21% | 5.63 |
| Hologic, Inc. (HOLX) | 1.57% | $18.18B | -0.85% | 55.27% | 4.77 |
| Okta, Inc. (OKTA) | 1.57% | $14.99B | 19.11% | 76.01% | 6.14 |
| Ventas, Inc. (VTR) | 1.57% | $21.53B | 11.39% | 17.99% | 6.72 |
| United Therapeutics Corp. (UTHR) | 1.57% | $14.92B | 33.70% | 89.24% | 3.73 |
| STERIS Plc (Ireland) (STE) | 1.56% | $22.50B | 3.65% | 43.55% | 4.97 |
| Carrier Global Corp. (CARR) | 1.55% | $58.41B | 11.63% | 28.27% | 2.91 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 1.55% | $127.03B | 14.21% | 87.25% | 9.80 |
| Quest Diagnostics, Inc. (DGX) | 1.54% | $16.06B | 2.52% | 32.37% | 2.17 |
| HCA Healthcare, Inc. (HCA) | 1.53% | $92.40B | 10.28% | 15.61% | 1.90 |
| Baxter International, Inc. (BAX) | 1.53% | $17.88B | -1.56% | 37.53% | 2.22 |
| Veeva Systems, Inc. (VEEV) | 1.52% | $30.16B | 23.56% | 73.26% | 11.23 |
| Agilent Technologies, Inc. (A) | 1.51% | $39.38B | -8.39% | 54.42% | 6.28 |
| Zimmer Biomet Holdings, Inc. (ZBH) | 1.51% | $22.76B | 3.18% | 61.90% | 4.38 |
| Alexandria Real Estate Equities, Inc. (ARE) | 1.51% | $20.29B | 7.40% | 33.75% | 12.32 |
| Laboratory Corp. of America Holdings (LH) | 1.50% | $17.78B | -15.92% | 26.36% | 1.98 |
| Leidos Holdings, Inc. (LDOS) | 1.50% | $20.55B | 7.46% | 16.05% | 1.43 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 1.50% | $115.32B | -0.54% | 82.58% | 7.86 |
| Intuitive Surgical, Inc. (ISRG) | 1.49% | $155.20B | 14.47% | 68.30% | 20.59 |
| Xylem, Inc. (XYL) | 1.49% | $33.25B | 40.11% | 37.04% | 4.13 |
| GE Healthcare Technologies, Inc. (GEHC) | 1.49% | $36.48B | -1.21% | 41.23% | 2.51 |
| ICON plc (ICLR) | 1.48% | $25.89B | 4.95% | 22.49% | 3.51 |
| EXACT Sciences Corp. (EXAS) | 1.48% | $8.92B | 5.82% | 69.66% | 5.73 |
| BioMarin Pharmaceutical, Inc. (BMRN) | 1.48% | $16.25B | 9.61% | 78.54% | 7.05 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 1.47% | $19.04B | 4.84% | 46.56% | 2.06 |
| Ecolab, Inc. (ECL) | 1.47% | $69.58B | 5.05% | 43.32% | 4.78 |
| McKesson Corp. (MCK) | 1.46% | $77.27B | 11.65% | 3.95% | 0.24 |
| Abbott Laboratories (ABT) | 1.46% | $184.33B | 4.00% | 55.96% | N/A |
| CVS Health Corp. (CVS) | 1.45% | $73.63B | 3.60% | 14.22% | 0.47 |
| Roper Technologies, Inc. (ROP) | 1.43% | $57.90B | 12.12% | 69.51% | 10.34 |
| Jabil, Inc. (JBL) | 1.43% | $12.52B | -20.18% | 8.82% | 0.50 |
| Medtronic Plc (MDT) | 1.42% | $100.61B | 3.64% | 60.11% | 3.84 |
| Stryker Corp. (SYK) | 1.42% | $124.74B | 9.73% | 60.92% | 7.10 |
| Merck & Co., Inc. (MRK) | 1.41% | $318.75B | 8.38% | 75.11% | 5.96 |
| Boston Scientific Corp. (BSX) | 1.41% | $109.18B | 14.48% | 69.17% | N/A |
| Cencora, Inc. (COR) | 1.41% | $45.30B | 7.81% | 3.30% | 0.19 |
| ResMed, Inc. (RMD) | 1.40% | $30.61B | 7.17% | 56.94% | 6.57 |
| IDEXX Laboratories, Inc. (IDXX) | 1.39% | $38.87B | 7.10% | 61.60% | 12.35 |
| Insulet Corp. (PODD) | 1.39% | $13.37B | 23.35% | 70.16% | 7.46 |
| Cardinal Health, Inc. (CAH) | 1.38% | $23.60B | 8.76% | 3.43% | 0.13 |
| Biogen, Inc. (BIIB) | 1.38% | $33.11B | -5.62% | 68.65% | 4.02 |
| Quanta Services, Inc. (PWR) | 1.37% | $36.42B | 13.62% | 10.85% | 1.97 |
| Tencent Holdings Ltd. (TCEHY) | 1.37% | $415.60B | 1.22% | 51.12% | 4.31 |
| Eli Lilly & Co. (LLY) | 1.33% | $780.46B | 25.98% | 80.91% | 20.23 |
| Align Technology, Inc. (ALGN) | 1.33% | $17.02B | 2.63% | 70.65% | 4.43 |
| West Pharmaceutical Services, Inc. (WST) | 1.25% | $20.19B | -6.92% | 32.95% | 8.39 |
| Walgreens Boots Alliance, Inc. (WBA) | 1.08% | $9.94B | 2.64% | 16.10% | 0.34 |
| Edwards Lifesciences Corp. (EW) | 1.00% | $35.98B | -9.43% | 79.56% | 9.10 |
| DexCom, Inc. (DXCM) | 0.80% | $42.89B | 15.26% | 62.40% | N/A |
